Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$31.57 - $37.73 $4.92 Million - $5.88 Million
-155,969 Reduced 50.31%
154,068 $5.75 Million
Q1 2023

May 09, 2023

BUY
$29.72 - $41.45 $4.05 Million - $5.65 Million
136,273 Added 78.42%
310,037 $9.91 Million
Q4 2022

Feb 10, 2023

BUY
$30.23 - $38.71 $5.25 Million - $6.73 Million
173,764 New
173,764 $6.2 Million
Q1 2022

May 12, 2022

SELL
$34.38 - $65.77 $1.07 Million - $2.04 Million
-31,082 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$63.78 - $97.86 $3.66 Million - $5.61 Million
-57,327 Reduced 64.84%
31,082 $2.19 Million
Q3 2021

Nov 12, 2021

BUY
$45.58 - $88.24 $4.03 Million - $7.8 Million
88,409 New
88,409 $14.1 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.49B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.